Charles Bury
About Charles Bury
Charles Bury is a Discovery Data Scientist at Exscientia, specializing in AI-based drug discovery. He holds a DPhil in Systems Biology from the University of Oxford and has experience in cheminformatics and machine learning.
Work at Exscientia
Charles Bury has been employed at Exscientia as a Discovery Data Scientist since 2021. His role focuses on utilizing data science techniques to support drug discovery initiatives. Based in Oxford, England, he contributes to projects that integrate artificial intelligence with drug development processes. His work aims to enhance the efficiency and effectiveness of discovering new therapeutic compounds.
Education and Expertise
Charles Bury studied at the University of Oxford, where he earned a DPhil in Systems Biology DTC from 2013 to 2017. He also holds an MMath with honours in Mathematics from the University of Warwick, completed between 2009 and 2013. His educational background provides a strong foundation in structural biology, cheminformatics, and machine learning, which he applies in his current role and previous positions.
Background
Charles Bury attended The King's School Chester from 1998 to 2009, completing his secondary education before pursuing higher studies. He began his professional career as a Cheminformatics intern at Medicines Discovery Catapult in 2018, followed by a role as a Cheminformatics Data Scientist from 2018 to 2021. He also worked briefly as a Postdoctoral Research Associate at the University of Oxford in 2017.
Achievements in AI-Based Drug Discovery
Charles Bury has extensive experience in AI-based drug discovery, where he combines his knowledge of cheminformatics, machine learning, structural biology, and mathematics. He has worked on AI-driven projects that leverage machine learning techniques to improve drug development processes. His contributions span both academic and industry settings, focusing on advancements in structural biology and cheminformatics.